1. Home
  2. RITM vs LEGN Comparison

RITM vs LEGN Comparison

Compare RITM & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rithm Capital Corp.

RITM

Rithm Capital Corp.

HOLD

Current Price

$10.70

Market Cap

6.5B

Sector

Real Estate

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$18.54

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RITM
LEGN
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RITM
LEGN
Price
$10.70
$18.54
Analyst Decision
Strong Buy
Buy
Analyst Count
8
14
Target Price
$14.56
$63.46
AVG Volume (30 Days)
10.8M
3.1M
Earning Date
02-03-2026
03-10-2026
Dividend Yield
9.37%
N/A
EPS Growth
N/A
N/A
EPS
1.04
N/A
Revenue
$3,136,826,000.00
$909,045,000.00
Revenue This Year
N/A
$67.56
Revenue Next Year
$4.04
$45.77
P/E Ratio
$10.26
N/A
Revenue Growth
N/A
74.75
52 Week Low
$9.13
$16.24
52 Week High
$12.74
$45.30

Technical Indicators

Market Signals
Indicator
RITM
LEGN
Relative Strength Index (RSI) 37.68 42.75
Support Level $10.53 $16.82
Resistance Level $10.87 $17.38
Average True Range (ATR) 0.32 0.78
MACD -0.11 0.17
Stochastic Oscillator 11.76 61.55

Price Performance

Historical Comparison
RITM
LEGN

About RITM Rithm Capital Corp.

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: